Mefenamic Acid
NDC Package 60258-890-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mefenamic Acid is used for the short-term treatment of mild to moderate pain from various conditions. Marketed by Cypress Pharmaceutical, Inc., this product is identified by NDC 60258-890 and is authorized under FDA application ANDA090359.

Identification & Billing

NDC Package Code
60258-890-01
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
60258-890
11-Digit Billing Format
60258089001

Clinical Specifications

Proprietary Name
Mefenamic Acid
Dosage Form
-
Usage Information
Mefenamic acid is used for the short-term treatment of mild to moderate pain from various conditions. It is also used to decrease pain and blood loss from menstrual periods. Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID).

Regulatory & Marketing

Labeler Name
Cypress Pharmaceutical, Inc.
FDA Application #
ANDA090359
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-03-2013
End Marketing Date
09-11-2013
Listing Expiration
09-11-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60258-890-01 identifies a specific commercial package of 100 capsule in 1 bottle of Mefenamic Acid, labeled by Cypress Pharmaceutical, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cypress Pharmaceutical, Inc. on June 03, 2013. The current certification is valid through September 11, 2013.

What are the primary indications for this medication?

Mefenamic acid is used for the short-term treatment of mild to moderate pain from various conditions. It is also used to decrease pain and blood loss from menstrual periods. Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID).

How is this Cypress Pharmaceutical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60258089001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60258-890-01
11-Digit CMS (5-4-2)
60258-0890-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.